Brief: Sun Pharma Says Receives ANVISA Approval To Manufacture And Market Semaglutide In Brazil
BRIEF-Sun Pharma Says Receives ANVISA Approval To Manufacture And Market Semaglutide In Brazil July 29 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - PHARMA RECEIVES ANVISA APPROVAL TO MANUFACTURE AND MARKET SEMAGLUTIDE IN BRAZIL
SUN PHARMA - PHARMA TO LAUNCH SEMAGLUTIDE IN BRAZIL WITH HYPERA PHARMA
SUN PHARMA - SEMAGLUTIDE TO BE AVAILABLE IN 2 MG/1.5 ML AND 4 MG/3 ML STRENGTHS
Source text: ID:nNSE6hJ79b
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses